Status:
UNKNOWN
Pulmonary Rehabilitation in Interstitial Lung Disease
Lead Sponsor:
The Alfred
Collaborating Sponsors:
La Trobe University
Austin Hospital, Melbourne Australia
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
40-90 years
Phase:
NA
Brief Summary
Interstitial lung disease (ILD) is a highly disabling group of conditions including idiopathic pulmonary fibrosis (IPF), acute and chronic interstitial pneumonias, connective tissue diseases and sarco...
Detailed Description
Interstitial lung disease (ILD) is a highly disabling group of conditions including idiopathic pulmonary fibrosis (IPF), acute and chronic interstitial pneumonias, connective tissue diseases and sarco...
Eligibility Criteria
Inclusion
- Ambulant
- Stable medical therapy
- Dyspnoea on exertion following maximal treatment
Exclusion
- A history of syncope on exertion
- Too unwell to attend the hospital for exercise training
- Any other comorbidities which would prevent exercise training
- Previous Pulmonary Rehabilitation in the last 12 months
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00168285
Start Date
March 1 2005
End Date
May 1 2007
Last Update
April 5 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Alfred Hospital
Melbourne, Victoria, Australia, 3004
2
Austin Hospital
Melbourne, Victoria, Australia, 3084